Key result
A 9-week-old infant with a complex congenital heart defect and congestive heart failure was found to have elevated cardiac troponin, highlighting the potential utility of cardiac markers in this group.
Case Report (n=1)
Cardiac troponin evaluation should be considered in infants with congestive heart failure to identify myocardial damage and risk of complications.
Hypothesis-generating for troponin in infants with CHD and HF; leaves open prospective validation before clinical adoption.
Myocardial ischemia in children is generally not suspected when they present to an emergency department with congestive heart failure. However, the opposite holds true for an adult patient. Elevated cardiac troponin is a specific biochemical marker for myocardial damage for both adults and children, however, they have not been routinely used in children at risk for myocardial damage. A case is presented of an infant with a complex congenital heart defect with congestive heart failure who was found to have an elevated cardiac troponin. Infants at risk for myocardial damage should have an evaluation of cardiac markers, as infants with elevated levels are prone to dysrhythmias or worsening cardiac function and thus warrant closer observations and therapy.
No takes yet. Share an insight, caveat, or question.
Antonio E. Mu iz (2004) conducted a case report in Congestive heart failure and complex congenital heart defect (n=1). Cardiac troponin evaluation was evaluated on Elevated cardiac troponin. A 9-week-old infant with a complex congenital heart defect and congestive heart failure was found to have elevated cardiac troponin, highlighting the potential utility of cardiac markers in this group.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: